a public good project by the
Synthesis
Company
of California

© 2026

Targeting myeloid-derived suppressor cells for cancer immunotherapy | doi.page

0 citations0 references

Google Scholar doi.org

Targeting myeloid-derived suppressor cells for cancer immunotherapy

Cancer Immunology Immunotherapy·2018·Vol. 67(8), pp. 1181–1195

Citations Over TimeTop 10% of 2018 papers

Yijun Liu, Guo‐Wei Wei, Wesley A. Cheng, Zhenyuan Dong, Han Sun, Vincent Y. Lee, Soung-Chul Cha, D. Lynne Smith, Larry W. Kwak, Hong Qin

Related Papers

→ Cellular Immune Suppressor Mechanisms in Patients with Hepatocellular Carcinoma(2012)37 cited
→ Myeloid-Derived Suppressor Cells in Some Oncohematological Diseases(2017)3 cited
Suppressor cells and malignancy. I. Suppressor macrophages and suppressor T cells in experimental animals.(1986)
→ Supplementary Data from Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells(2023)